Other highlights from the July 10 JNCI

ultidrug-resistant cells, compared with drug-sensitive cells. Blocking HDAC1 made the cells more sensitive to chemotherapy drugs that treat neuroblastoma.

This gene is of particular interest because [HDAC] inhibitors are a relatively new class of cancer chemotherapeutic agents undergoing preclinical testing for clinical development in the treatment of drug-resistant neuroblastoma, the authors write.

Contact: Steve Rutledge, director of communications, Childrens Hospital Los Angeles, srutledge@chla.usc.edu, (323) 361-4121

High Vitamin D Levels Are Associated with Reduced Colon Cancer Risk

A new study confirms an association between increased vitamin D levels and decreased risk of colon cancer.

Previous studies have shown that colon cancer mortality rates are lower in regions with greater sun exposure, which leads to vitamin D synthesis in the skin.

Kana Wu, M.D., Ph.D., of the Harvard School of Public Health in Boston and colleagues measured the levels of vitamin D in the blood plasma of 372 colorectal cancer patients and 739 controls. They used data from the Health Professionals Follow-up Study and the Nurses Health Study.

In the health professionals study, the researchers found an association between higher concentrations of vitamin D in patients plasma and reduced risk of colon cancer and colorectal cancer, though the latter link was not statistically significant. When combining data from both studies, the association held up for both colon and colorectal cancer.

In conclusion, our data provide additional support for an inverse association between vitamin D and colorectal and in particular colon cancer risk, the authors write.

Contact: Robin Herman, assistant dean of communications, Harvard School of Public Health, rherman@hsph.harvard.edu


Contact: Liz Savage
Journal of the National Cancer Institute

Page: 1 2

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights in JNCI, June 26
4. Other highlights in JNCI, June 12
5. Other highlights from the June 6 JNCI
6. Other highlights in the May 16 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:

(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer ... New Jersey-based Critical Environments Group (CEG) to market and sell its complete line of ... center and IT environment infrastructure optimization solutions . , Brett Mason, CrucialTrak’s ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... for adjunct liquefaction: AMYLEX® 6T. The innovative enzyme enables numerous business gains ... segments with locally-sourced raw materials, improve productivity, maximize yield, ensure consistent quality ...
(Date:5/26/2020)... , ... May 26, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., ... receptor (TCR)-mimetic bispecific T cell engagers and TCR-based therapeutics, has implemented ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... With the ... vaccine or drug treatment. In an effort to better understand the cellular responses ... world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 approved and ...
(Date:6/23/2020)... BOSTON (PRWEB) , ... June 23, 2020 , ... ... to facilitate access to unique lab-made bioresearch materials, today announced the availability of ... Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry ...
(Date:6/23/2020)... , ... June 22, 2020 , ... ... glutamine antagonist, DRP-104, will be presented June 22-24 during the American Association for ... DRP-104; and, the other profiles the potent, consistent single agent activity in KEAP1 ...
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, ... through the use of proprietary clean viral vectors, recently announced a key manufacturing ... Greffex’s platform is the world’s most successful gene therapy delivery vehicle (vector) ...
Breaking Biology Technology:
Cached News: